Status:
ENROLLING_BY_INVITATION
Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Melanoma
Adenocarcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Background: The NCI Surgery Branch has developed experimental therapies that involve taking white blood cells from participants' tumor or from their blood, growing them in the laboratory in large num...
Detailed Description
Background: * Patients receiving care at the NIH Clinical Center are required to be enrolled on a clinical protocol. * Following participation in a treatment protocol, it may be in the best interest ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Age greater than or equal to 18 years.
- Participants who have received treatment on an NCI-SB protocol, including gene therapy protocols. (Note: Participants may be enrolled on this protocol and, at the same time, participate in an active treatment study).
- For Cohort A:Ability of participant or Legally Authorized Representative (LAR) to understand and the willingness to sign a written informed consent document. For Cohort B: Participant is able to provide informed consent.
- EXCLUSION CRITERIA:
- For Cohort B: Individuals of child-bearing potential (IOCBP) who are pregnant or plan to become pregnant because of the potentially dangerous effects of the investigational treatments administered on NCI-SB treatment protocols.
Exclusion
Key Trial Info
Start Date :
June 15 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
1150 Patients enrolled
Trial Details
Trial ID
NCT00923026
Start Date
June 15 2009
Last Update
January 8 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892